Boeing is positioned to demonstrate ‘sustained positive momentum’ in 2025, write Barclays analysts led by David Strauss.

Boeing (NYSE:BA) on Monday was upgraded to Overweight from a previous investment rating Equal Weight by analysts at financial-services firm Barclays. They said the aviation and defense company is poised to gain as its output of planes,

In a report released today, David E. Strauss from Barclays maintained a Buy rating on Boeing (BA – Research Report), with a price target of

TD Cowen analyst Gautam Khanna reiterated a Buy rating on Boeing (BA – Research Report) on January 14 and set a price target of $200.00. The

Analysts at London-based multinational bank Barclays are speculating that Boeing’s stocks could be on the uptick to recovery this year.

"My number one pick in every sector is Boeing," says Stephanie Link, chief investment strategist at Hightower Advisors. Her top airline pick is Delta.

Boeing Co (BA) stock saw a decline, ending the day at $171.76 which represents a decrease of $-0.75 or -0.43% from the prior close of $172.51. The stock opened at $171.15 and touched a low of $169.61 during the day,

Boeing (NYSE:BA – Get Free Report) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued on Monday,Finviz reports. The brokerage currently has a $210.

That bet paid off. That same trend of aircraft demand is the main pillar for a Boeing rebound. David Strauss, an equity analyst with Barclays, articulated the bullish argument well in a Jan. 6 ...

Investors with a lot of money to spend have taken a bearish stance on Boeing BA. And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Some observers are expecting smoother sailing ahead for Boeing. Barclays (BCS) upgraded its rating on the company’s stock Monday to “overweight,” its first positive outlook since 2019.

Investing.com-- Barclays upgraded Boeing Co (NYSE: BA) to "overweight" for the first time since 2019, raising its price target to $210 from $190 banking on a brighter outlook for free cash flow and operational improvements.